These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1797482

  • 1. Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.
    Watanabe RM, Vølund A, Bergman RN.
    Diabetes Care; 1991 Nov; 14(11):1021-30. PubMed ID: 1797482
    [Abstract] [Full Text] [Related]

  • 2. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
    Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T.
    Diabetes Care; 2000 Sep; 23(9):1343-7. PubMed ID: 10977030
    [Abstract] [Full Text] [Related]

  • 3. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 4. Effects of hyperinsulinemia on the subsequent hormonal response to hypoglycemia in conscious dogs.
    Davis SN, Dobbins R, Colburn C, Tarumi C, Jacobs J, Neal D, Cherrington AD.
    Am J Physiol; 1993 May; 264(5 Pt 1):E748-55. PubMed ID: 8498496
    [Abstract] [Full Text] [Related]

  • 5. Evidence that carotid bodies play an important role in glucoregulation in vivo.
    Koyama Y, Coker RH, Stone EE, Lacy DB, Jabbour K, Williams PE, Wasserman DH.
    Diabetes; 2000 Sep; 49(9):1434-42. PubMed ID: 10969826
    [Abstract] [Full Text] [Related]

  • 6. The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans.
    Davis SN, Goldstein RE, Jacobs J, Price L, Wolfe R, Cherrington AD.
    Diabetes; 1993 Feb; 42(2):263-72. PubMed ID: 8425662
    [Abstract] [Full Text] [Related]

  • 7. Does insulin species modify counterregulatory hormone response to hypoglycemia?
    Jones TW, Caprio S, Diamond MP, Hallarman L, Boulware SD, Sherwin RS, Tamborlane WV.
    Diabetes Care; 1991 Aug; 14(8):728-31. PubMed ID: 1954809
    [Abstract] [Full Text] [Related]

  • 8. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [Abstract] [Full Text] [Related]

  • 9. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
    Banarer S, McGregor VP, Cryer PE.
    Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of beta-adrenergic blockade on hepatic and renal glucose production during hypoglycemia in conscious dogs.
    Cersosimo E, Zaitseva IN, Ajmal M.
    Am J Physiol; 1998 Nov; 275(5):E792-7. PubMed ID: 9814998
    [Abstract] [Full Text] [Related]

  • 13. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P.
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [Abstract] [Full Text] [Related]

  • 14. Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.
    Stevenson RW, Tsakok TI, Parsons JA.
    Diabetologia; 1980 May; 18(5):423-6. PubMed ID: 7000596
    [Abstract] [Full Text] [Related]

  • 15. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
    Shiota M, Galassetti P, Monohan M, Neal DW, Cherrington AD.
    Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
    [Abstract] [Full Text] [Related]

  • 16. Putative hypothalamic glucoreceptors play no essential role in the response to moderate hypoglycemia.
    Cane P, Artal R, Bergman RN.
    Diabetes; 1986 Mar; 35(3):268-77. PubMed ID: 3005093
    [Abstract] [Full Text] [Related]

  • 17. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
    Kerr D, Tamborlane WV, Rife F, Sherwin RS.
    J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
    [Abstract] [Full Text] [Related]

  • 18. Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog.
    Connolly CC, Adkins-Marshall BA, Neal DW, Pugh W, Jaspan JB, Cherrington AD.
    Diabetes; 1992 Oct; 41(10):1308-19. PubMed ID: 1397705
    [Abstract] [Full Text] [Related]

  • 19. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM, Dunn FL, Bruch J, McKitrick C, Larkin M, Haggan C, Lavin-Tompkins J, Norman D, Rogers D, Simon D.
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group.
    Kelley DE, Henry RR, Edelman SV.
    Diabetes Care; 1996 Nov; 19(11):1237-42. PubMed ID: 8908387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.